Navigation Links
University of Chicago and Ataxia Foundation team up for annual scientific and patient meetings
Date:3/5/2010

ing

TUESDAY MARCH 9, 2010

7 PM Opening Remarks Christopher M. Gomez
KEYNOTE ADDRESS Christian Hansel, University of Chicago, "Cerebellar Learning and Connectivity"

WEDNESDAY MARCH 10, 2010

8:00 AM Theme 1 Cerebellar Function (and episodic) Dysfunction
8:00 AM Episodic ataxias: an overview, Joanna C. Jen, UCLA
8:30 AM Episodic ataxias: physiological mechanisms, Ellen Hess, Emory University
9:00 AM The therapeutic mode of action of 4-AP in Episodic ataxia, K Khodakhah, Albert Einstein College of Medicine

Theme 2 Molecular pathogenesis of autosomal dominant ataxias
10:00 AM SCA2 and SCA13, Stefan M. Pulst, University of Utah
10:30 AM SCA3, Henry L. Paulson, University of Michigan
11:00 AM SCA6, Christopher M. Gomez, University of Chicago
1:15 PM Invited Junior Lecturer Paula Ladd, University of California, San Diego
1:40 PM Invited Junior Lecturer Mirella Dottori, University of Melbourne
2:05 PM SCA7, Albert R. LaSpada, UCSD
2:35 PM SCA17, Xiao-Jiang Li, Emory University
3:30 PM SCA5 and SCA8, Laura PW Ranum, University of Minnesota
4:00 PM SCA10, Tee Ashizawa, University of Florida, Gainesville
4:30 PM Molecular pathophysiology of SCA14 caused by gamma PKC mutations, Norio Sakai, Hiroshima University, Hiroshima, Japan
5:00 PM Perspectives on dominant ataxia: insights from SCA1 that apply to other spinocerebellar ataxias, Harry T. Orr, University of Minnesota
5:30 PM KEYNOTE ADDRESS Richard Morimoto, Northwestern University, "The Proteostasis Challenge: The Stress of Misfolded Proteins in Aging and Disease"

THURSDAY MARCH 11, 2010

Theme 3 Molecular pathogenesis of recessively inherited ataxias
8:00 AM KEYNOTE ADDRESS Keith Caldecott University of Sussex, "Defects in DNA Single-Strand Break Repair and 8:45 AM The function of ATM in the central nervous system: beyond DNA breaks, Karl
'/>"/>

Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Charles Drew University, UC Irvine awarded $480,000 grant for research low birth weight infants
2. New University of Colorado paper shows novel way to study human inflammatory disease
3. University of Colorado study shows natural antioxidants give top barn swallows a leg on competitors
4. Stacking traits in algae is focus of grant to Iowa State University researcher
5. University of Minnesota scientist finds that big plant seeds dont always beat out small seeds
6. University of Oklahoma study reveals red hot results
7. Research at Marshall University may lead to new ways to transport and manipulate molecules
8. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
9. Case Western Reserve University works with Johnson & Johnson Services Inc. on research grant
10. University of the Basque Country researchers decode transcriptome for gray mullet
11. Oxford University Press enters publishing partnership with Infectious Diseases Society of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... DENVER (Feb. 21, 2013) A new study from the ... practices in Eurasia varied widely, with some graves lavish and ... don,t know why some of these burials were so ornate, ... modern humans in Europe by almost 10,000 years," said Julien ...
... SOLOMONS, MD (February 21, 2013)--Biologists Jackie Grebmeier and Lee Cooper ... Biological Laboratory have been visiting the chilly area north of ... but it,s only in the last few years that they ... summer was the highest ice retreat in the Arctic record, ...
... NY, February 20, 2013As the nations of the world ... in endangered sharks in early March, a team of ... the oceanic whitetip shark regularly crosses international boundaries. ... predator within their own maritime borders may therefore need ...
Cached Biology News:Early human burials varied widely but most were simple 2Early human burials varied widely but most were simple 3Biologists lead international team to track Arctic response to climate change 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 3
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
(Date:7/24/2014)... WIRB-Copernicus Group ® ("WCG")™, the ... services for clinical research, announced today that it ... Richmond, VA -based Alliance Engineering, ... consulting firm in the United States ... – WCG Biosafety™ – will be able to ...
(Date:7/24/2014)... Toronto, Canada (PRWEB) July 24, 2014 ... for Optimizing Dose Escalation in First in Human Studies” ... to make better go/no-go decisions. , With increasing R&D ... market, pharmaceutical companies need to maximize the knowledge collected ... go/no-go decisions and improve success in late stage development. ...
(Date:7/24/2014)...  Spherix Incorporated (SPEX) -- an intellectual property development ... property, today announced that the Company will issue a ... on Monday, August 18, 2014 for shareholders. Management has ... Monday, August 18, 2014 to discuss the company,s progress ... Anthony Hayes . Following prepared remarks, ...
Breaking Biology Technology:Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Spherix Schedules Shareholder Update Call 2
... Companies Also Sign Manufacturing and Distribution Agreement, ... 15 Ranbaxy,Pharmaceuticals Inc. (RPI), a wholly ... today that it has reached several,agreements with ... capsules. The third agreement pertains to Omeprazole ...
... Symbol: MS, EDMONTON, April 15 /PRNewswire-FirstCall/ - ... the treatment of multiple sclerosis (MS), today,announced that ... data from the Company,s on-going MAESTRO-03 U.S. pivotal ... of secondary progressive MS and,recommended that the trial ...
... 15 Emisphere,Technologies, Inc. (Nasdaq: EMIS ), ... Meeting on Thursday, May 8, 2008, at the ... New Jersey. The,meeting will begin at 10:00 a.m. ... Technologies, Inc. is a biopharmaceutical company that,focuses on ...
Cached Biology Technology:Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 2Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 3BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2
Human SIGIRR MAb (Clone 162201)...
... 1. 1000 V, 400 mA, 100 ... constant power modes.Single-unit increments in settings ... and recalls three protocols.Outstanding choice for ... Multiphor II or GenePhor systems. Category: ...
Mouse Serpin F1/PEDF MAb (Clone 199315)...
Mouse Nodal Affinity Purified Polyclonal Ab...
Biology Products: